ADVENTRX Pharmaceuticals (ANX) Tops Q4 EPS by 3c

March 7, 2012 4:31 PM EST
ADVENTRX Pharmaceuticals (NYSE: ANX) reported Q4 EPS of ($0.06), $0.03 better than the analyst estimate of ($0.09).

For earnings history and earnings-related data on ADVENTRX Pharmaceuticals (ANX) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings